Unlocking The Cannabis Genome - CannMed 25 Innovation & Investment Summit скачать в хорошем качестве

Unlocking The Cannabis Genome - CannMed 25 Innovation & Investment Summit

Tags: Cultivation, Cannabis Breeding, Cannabis Genomics Tools, Trait Selection, Genetic Editing, CRISPR Moderator: Karl Ravet ‪@advancednutrients‬ Panelists: Michael Petersen (Wisconsin Crop Innovation Center) , Todd Michael ‪@salkinstitute‬ , Kevin McKernan ‪@medicinal.genomics‬ , and Gabriel Krouk ‪@CNRS‬ This session delves into the powerful role of genomics in cannabis and modern agriculture. Panelists will introduce key concepts in cannabis genomics, discuss the current landscape of genetic knowledge, and highlight the unexplored potential within the cannabis genome. Attendees will discover how genomics is uncovering genetic diversity and enabling the identification of valuable traits, from pest resistance to enhanced yield. Through tools like marker-assisted selection (MAS),genome-wide association studies (GWAS), and genome editing (CRISPR), participants will learn how to leverage these innovations in breeding programs. Case studies will showcase the practical applications of genomics, demonstrating its transformative impact on developing resilient, high-performing cannabis varieties. Key Topics Covered: ⦾ Fundamentals of genomics in agriculture and cannabis ⦾ Current understanding and mysteries within the cannabis genome ⦾ Exploring genetic diversity to pinpoint valuable traits ⦾ Advanced breeding tools: MAS, GWAS, and CRISPR ⦾ Real-world case studies in genomics-driven breeding success Learn More about CannMed: https://cannmedevents.com/ Sign Up for Our Newsletter: https://share.hsforms.com/1oi57oJDnRN... The CannMed 25 Innovation & Investment Summit showcased its first international venue, the Wyndham Grand Rio Mar Golf & Beach Resort in Puerto Rico from June 17 - 20, 2025. Since its inception at Harvard Medical School in 2016, CannMed has earned a reputation as the premier destination for cutting-edge research, emerging technologies, and investment opportunities. CannMed 25 continues this tradition with medicinal plant researchers, clinicians and venture capitalists who view this Summit as the industry’s number one showcase for the latest advances in plant-based science, medicine, cultivation, and safety.